Therapeutic role of isoflavones from traditional medicine in the management of polycystic ovary syndrome

Ashwini Armarkar , Prafulla Sabale , Satyendra Prasad , Vidya Sabale , Lata Potey , Dipti Masram
{"title":"Therapeutic role of isoflavones from traditional medicine in the management of polycystic ovary syndrome","authors":"Ashwini Armarkar ,&nbsp;Prafulla Sabale ,&nbsp;Satyendra Prasad ,&nbsp;Vidya Sabale ,&nbsp;Lata Potey ,&nbsp;Dipti Masram","doi":"10.1016/j.prmcm.2025.100580","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Polycystic ovary syndrome (PCOS) is a significant public health problem and one of the most common gynaecological and endocrine disorder.This condition affects an estimated 8–13 % of women of reproductive age worldwide. PCOS manifests as a group of symptoms, including oligomenorrhea, obesity, infertility, increased risk of diabetes, acne, and hirsutism. The etiology of PCOS involves a complex interplay of factors, including genetic predisposition, neuroendocrine dysregulation, contemporary lifestyle practices, and obesity. Numerous traditional chinese formulations have demonstrated success in mitigating PCOS symptoms and addressing its underlying causes.</div></div><div><h3>Methodology</h3><div>Online databases such as Google Scholar, PubMed, and ScienceDirect Library were employed to find literatures on “Polycystic ovary syndrome,” “Phytoestrogens,” “Pharmacokinetics of Isoflavones” Role of isoflavones in PCOS. considering articles published in the last 20 years to capture recent research.This review summarizes the scientific findings on traditional herbs rich in isoflavones and their bioactive components of the phytoestrogen class for the management of PCOS.</div></div><div><h3>Result</h3><div>Isoflavones, a subset of polyphenolic compounds, represent a prominent class of phytoestrogens. These secondary plant metabolites, which predominantly occur in the Fabaceae family, exhibit structural similarities to 17β-estradiol, and typically exist in conjugated forms. The estrogenic properties of isoflavone phytoconstituents, such as genistein, biochanin A, daidzein, puerarin, and formononetin, confer substantial therapeutic potential for PCOS management.</div></div><div><h3>Conclusion</h3><div>Despite their therapeutic potential, there is a paucity of data regarding the safety profile, clinical efficacy, and optimal treatment duration of isoflavones. Further investigations across various domains of isoflavone research are imperative to enhance the understanding of this complex field of study.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"14 ","pages":"Article 100580"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacological Research - Modern Chinese Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667142525000090","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Polycystic ovary syndrome (PCOS) is a significant public health problem and one of the most common gynaecological and endocrine disorder.This condition affects an estimated 8–13 % of women of reproductive age worldwide. PCOS manifests as a group of symptoms, including oligomenorrhea, obesity, infertility, increased risk of diabetes, acne, and hirsutism. The etiology of PCOS involves a complex interplay of factors, including genetic predisposition, neuroendocrine dysregulation, contemporary lifestyle practices, and obesity. Numerous traditional chinese formulations have demonstrated success in mitigating PCOS symptoms and addressing its underlying causes.

Methodology

Online databases such as Google Scholar, PubMed, and ScienceDirect Library were employed to find literatures on “Polycystic ovary syndrome,” “Phytoestrogens,” “Pharmacokinetics of Isoflavones” Role of isoflavones in PCOS. considering articles published in the last 20 years to capture recent research.This review summarizes the scientific findings on traditional herbs rich in isoflavones and their bioactive components of the phytoestrogen class for the management of PCOS.

Result

Isoflavones, a subset of polyphenolic compounds, represent a prominent class of phytoestrogens. These secondary plant metabolites, which predominantly occur in the Fabaceae family, exhibit structural similarities to 17β-estradiol, and typically exist in conjugated forms. The estrogenic properties of isoflavone phytoconstituents, such as genistein, biochanin A, daidzein, puerarin, and formononetin, confer substantial therapeutic potential for PCOS management.

Conclusion

Despite their therapeutic potential, there is a paucity of data regarding the safety profile, clinical efficacy, and optimal treatment duration of isoflavones. Further investigations across various domains of isoflavone research are imperative to enhance the understanding of this complex field of study.

Abstract Image

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信